REBEGLO-20 Injection

Description

Rapid Acid Management with REBEGLO-20 (Rabeprazole Injection IP)

REBEGLO-20 is a high-quality injectable formulation of Rabeprazole Sodium, a substituted benzimidazole that suppresses gastric acid secretion. By inhibiting the $H^+/K^+$-ATPase enzyme system (the “proton pump”) at the secretory surface of the gastric parietal cell, it provides a potent and long-lasting reduction in stomach acid production.

Key Therapeutic Indications:

• Gastroesophageal Reflux Disease (GERD): Rapidly alleviates symptoms of severe acid reflux and erosive esophagitis.

• Peptic & Duodenal Ulcers: Promotes the healing of stomach and intestinal ulcers by maintaining a controlled gastric pH.

• Zollinger-Ellison Syndrome: Effectively manages pathological hypersecretory conditions where excessive acid production occurs.

• Aspiration Prophylaxis: Often used pre-operatively to reduce the risk of acid aspiration during surgery.

• Alternative to Oral Therapy: Ideal for patients who are unable to take medication orally due to nausea, vomiting, or surgical recovery.

Why Choose REBEGLO-20?

• Immediate Onset: Bypasses the digestive tract for faster systemic absorption and quicker symptom relief compared to tablets.

• Precision Dosing: The 20mg vial ensures accurate dosage for critical care and hospital settings.

• Quality Assured: Manufactured under strict pharmaceutical standards by Sycare Lifesciences to ensure sterile and pyrogen-free delivery.

Administration & Dosage:

• Route: For Intravenous (IV) use only.

• Dosage: As directed by a qualified physician or healthcare professional.

• Reconstitution: Must be reconstituted with the provided sterile water/saline before administration.

Safety Information: This is a prescription-only (Schedule H) medication. It must be administered by a registered medical practitioner or a trained nurse. Store in a cool, dry place and protect from light. Use the reconstituted solution immediately.